1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow RPR 109881A: new trials by email Literature Review of RPR 109881A trials Research Report on RPR 109881A
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Breast Cancer Trial of RPR109881 Versus Capecitabine in Male or Female Patients With Advanced Breast Cancer larotaxel (RPR109881, XRP9881), capecitabine - Breast Cancer, Metastases | Phase 3 | Completed | Sanofi | 438 | 2004-04-01 | 2008-08-21 |
Breast Neoplasms (1) · Neoplasm Metastasis (1)
Sanofi (1)
Argentina (1) · Australia (1) · Austria (1) · Brazil (1) · Canada (1) · Chile (1) · Colombia (1) · Czechia (1) · Finland (1) · France (1) · Germany (1) · Hungary (1) · Israel (1) · Italy (1) · Mexico (1)